13F filer · CIK 914208 ↗
Invesco Ltd.
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$330.04B
−16% on the quarter before
Positions
4,031
285 new · 251 sold out
Top 10
11.3%
of the value
Est. gain
−$56.66B
on stocks held all quarter
Est. return
−15.6%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Invesco Ltd.'s 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 18% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Heico Corp New~$884.1MAdded · 0.2% → 0.5%+8,389,921 shares
- Verizon Communications Inc~$446.9MAdded · 0.3% → 0.5%+8,805,836 shares
- Exxon Mobil Corp~$387.9MAdded · 0.3% → 0.5%+4,529,531 shares
- Zto Express Cayman Inc~$285.1MAdded · 0.2% → 0.3%+10,386,490 shares
- Abbvie Inc~$252.5MAdded · 0.3% → 0.4%+1,648,278 shares
- Amerisourcebergen Corp~$249.2MAdded · 0.1% → 0.2%+1,761,225 shares
- Roper Technologies Inc~$225.1MAdded · 0.1% → 0.2%+570,432 shares
- CrowdStrike~$212.8MAdded · 0.1% → 0.1%+1,262,407 shares
- Parker-Hannifin Corp~$207.4MAdded · 0.1% → 0.2%+842,738 shares
- Dexcom Inc~$201.5MAdded · 0.2% → 0.1%+2,703,328 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Qualcomm~$320.7MCut · 0.6% → 0.5%−2,510,661 shares
- Avantor Inc~$316.9MCut · 0.2% → 0.1%−10,190,489 shares
- Cdk Global Inc~$256.3MCut · 0.1% → 0.0%−4,678,911 shares
- Salesforce~$232.5MCut · 0.3% → 0.2%−1,409,039 shares
- Exelon Corporation~$230.5MCut · 0.3% → 0.2%−5,087,117 shares
- Invesco Exch Traded Fd Tr Ii~$215.6MCut · 0.1% → 0.0%−4,841,881 shares
- Philip Morris Intl Inc~$213.5MCut · 0.4% → 0.4%−2,161,816 shares
- Kkr & Co Inc~$210.8MCut · 0.1% → 0.0%−4,553,565 shares
- Intercontinental Exchange In~$191.4MCut · 0.2% → 0.1%−2,035,300 shares
- Hca Healthcare Inc~$189.4MCut · 0.3% → 0.2%−1,126,927 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +2.3% · price −16.7% | 2.4% | $8.08B | −$1.58B | ||||||||
| AppleCOM · shares −2.4% · price −21.7% | 1.9% | $6.21B | −$1.72B | ||||||||
| AlphabetCAP STK CL A · shares −1.3% · price −21.6% | 1.5% | $4.92B | −$1.36B | ||||||||
| AmazonCOM · shares +2.2% · price −38.1% | 1.3% | $4.14B | −$2.49B | ||||||||
| Unitedhealth Group IncCOM · shares +3.5% · price +0.7% | 0.97% | $3.20B | +$22.0M | ||||||||
| Johnson & JohnsonCOM · shares +5.6% · price +0.2% | 0.72% | $2.37B | +$3.5M | ||||||||
| Chevron Corp NewCOM · shares +8.4% · price −11.1% | 0.66% | $2.19B | −$251.8M | ||||||||
| MetaCL A · shares +6.8% · price −27.5% | 0.66% | $2.18B | −$773.5M | ||||||||
| Visa Inc.COM CL A · shares +7.4% · price −11.2% | 0.64% | $2.10B | −$246.6M | ||||||||
| Yum China Hldgs IncCOM · shares −1.0% · price +16.8% | 0.60% | $1.96B | +$281.9M | ||||||||
| AlphabetCAP STK CL C · shares −3.5% · price −21.7% | 0.55% | $1.80B | −$498.3M | ||||||||
| Coca Cola CoCOM · shares +5.9% · price +1.5% | 0.54% | $1.78B | +$24.2M | ||||||||
| Merck & Co IncCOM · shares −3.0% · price +11.1% | 0.54% | $1.77B | +$177.3M | ||||||||
| Wells Fargo Co NewCOM · shares −0.08% · price −19.2% | 0.53% | $1.75B | −$414.5M | ||||||||
| Bk Of America CorpCOM · shares −5.9% · price −24.5% | 0.50% | $1.66B | −$538.7M | ||||||||
| Heico Corp NewCL A · shares +115% · price −16.9% | 0.50% | $1.65B | −$155.9M | ||||||||
| Jd.Com IncSPON ADR CL A · shares +11% · price +11.0% | 0.49% | $1.62B | +$145.1M | ||||||||
| Exxon Mobil CorpCOM · shares +33% · price +3.7% | 0.48% | $1.57B | +$42.2M | ||||||||
| Raytheon Technologies CorpCOM · shares +1.7% · price −3.0% | 0.48% | $1.57B | −$47.6M | ||||||||
| Eli LillyCOM · shares +0.1% · price +13.2% | 0.47% | $1.56B | +$181.4M | ||||||||
| Cvs Health CorpCOM · shares −3.3% · price −8.4% | 0.47% | $1.55B | −$143.3M | ||||||||
| NvidiaCOM · shares −4.8% · price −44.4% | 0.47% | $1.54B | −$1.23B | ||||||||
| Verizon Communications IncCOM · shares +41% · price −0.4% | 0.47% | $1.54B | −$4.1M | ||||||||
| QualcommCOM · shares −17% · price −16.4% | 0.46% | $1.53B | −$301.3M | ||||||||
| Elevance Health IncCOM · shares +3.4% · price −1.8% | 0.45% | $1.48B | −$25.6M | ||||||||
| Total · 4,031 positions | 100% | $330.04B | −$56.66B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 3,607 stocks held throughout, down $56.66B (−15.6%).
- Yum China Hldgs Inc+$281.9M+17%
- Eli Lilly+$181.4M+13%
- Merck & Co Inc+$177.3M+11%
- Huazhu Group Ltd+$161.2M+15%
- Jd.Com Inc+$145.1M+11%
- Nvidia−$1.23B−44%
- Alphabet−$1.36B−22%
- Microsoft−$1.58B−17%
- Apple−$1.72B−22%
- Amazon19:1 split−$2.49B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 12 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.26T+23% | SEC ↗ |
| Q1 2026 | May 12, 2026 (amended) | $1.02T−3% | SEC ↗ |
| Q4 2025 | Feb 19, 2026 (amended) | $1.06T+67% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $634.72B+8% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $587.99B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $527.93B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $540.90B+4% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $517.95B+10% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $472.84B+2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $465.56B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $420.24B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.30B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $381.45B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $358.48B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $341.42B+10% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $310.69B−6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $330.04B−16% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $392.05B−5% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $414.84B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $394.59B−3% | SEC ↗ |
| Q2 2021 | Aug 17, 2021 | $406.58B+9% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $374.71B+9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $343.59B+16% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $295.82B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $279.68B+18% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $237.58B−26% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $322.08B−16% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $382.36B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 (amended) | $388.53B+31% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $296.53B+14% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $261.24B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $317.79B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $302.15B+13% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $267.56B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $277.31B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.72B−16% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $321.34B+5% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $304.59B+2% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $297.54B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $291.04B+7% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $272.23B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $246.04B | SEC ↗ |